Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Cellular Biomedicine Group, Inc. | Financial_Report.xls |
| 10-K/A - AMENDMENT NO 1 TO 10-K - Cellular Biomedicine Group, Inc. | cmbg_10ka.htm |
| EX-10.26 - SECURITIES PURCHASE AGREEMENT - Cellular Biomedicine Group, Inc. | cmbg_ex26.htm |
| EX-10.25 - FORM OF LISTING AGREEMENT - Cellular Biomedicine Group, Inc. | cmbg_ex24.htm |
| EX-31.1 - CERTIFICATION - Cellular Biomedicine Group, Inc. | cmbg_ex311.htm |
| EX-23.1 - CONSENT - Cellular Biomedicine Group, Inc. | cmbg_ex231.htm |
| EX-31.2 - CERTIFICATION - Cellular Biomedicine Group, Inc. | cmbg_ex312.htm |
| EX-32.1 - CERTIFICATION - Cellular Biomedicine Group, Inc. | cmbg_ex321.htm |
Exhibit 32.2
CERTIFICATION OF PRINCIPAL FINANCIAL & ACCOUNTING OFFICER
PURSUANT TO 18 USC § 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002
In connection with the annual report of Cellular Biomedicine Group, Inc. (the “Company”) on Form 10-K for the fiscal year ended December 31, 2012 as filed with the Securities and Exchange Commission (the “Report”), I, Andrew Chan, Chief Financial Officer (Principal Financial and Accounting Officer) of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to the best of my knowledge:
|
(1)
|
The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and
|
|
(2)
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the date and for the periods indicated.
|
|
Date: June 18, 2013
|
By:
|
/s/ Andrew Chan | |
| Andrew Chan | |||
|
Chief Financial Officer (Principal Financial and Accounting Officer)
|
|||